Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Advanced Tech.
5 min read
"The Regulator" in Cancer Treatment: Interleukins
12 October 2023
Interleukins (IL), also known as "white cell stimulators," are a type of cytokines first found to be produced by white blood cells and act between them.
Latest Hotspot
3 min read
AbbVie shares findings from its Phase 3 trial involving Venetoclax for individuals with Multiple Myeloma
12 October 2023
AbbVie shared Phase 3 CANOVA trial results for the VenDex combo in treating relapsed or resistant multiple myeloma in patients with two or more prior treatments.
Drug Insights
4 min read
A Comprehensive Review of brimonidine tartrate/timolol maleate's R&D Innovations and Drug Target Mechanism
12 October 2023
This article summarized the latest R&D progress of brimonidine tartrate/timolol maleate, the Mechanism of Action for brimonidine tartrate/timolol maleate, and the drug target R&D trends for brimonidine tartrate/timolol maleate.
Latest Hotspot
3 min read
JCR Pharmaceuticals Reveals Findings from Phase I/II Research of JR-171 in people with Mucopolysaccharidosis Type I
12 October 2023
JCR Pharmaceuticals Co., Ltd. has disclosed critical findings from the midway 52-week data of its global research phase I/II involving JR-171 (lepunafusp alfa) in patients diagnosed with mucopolysaccharidosis type I.
Drug Insights
5 min read
Pharmaceutical Insights: alverine citrate's R&D Progress and its Mechanism of Action on Drug Target
12 October 2023
This article summarized the latest R&D progress of alverine citrate, the Mechanism of Action for alverine citrate, and the drug target R&D trends for alverine citrate.
Bio Sequence
3 min read
Exploring the World of Sequence IP with Patsnap Bio
12 October 2023
In the rapidly escalating field of biological research, the importance of intellectual property (IP) has never been more critical. With biological sequences becoming paramount in the biotech and pharmaceutical sectors, the advent of a convenient, comprehensive patent search database is indeed a significant breakthrough.
Drug Insights
5 min read
Exploring alefacept's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
11 October 2023
This article summarized the latest R&D progress of alefacept, the Mechanism of Action for alefacept, and the drug target R&D trends for alefacept.
Latest Hotspot
3 min read
Geron Reports Validation by EMA of Marketing Approval Submission for Imetelstat
11 October 2023
Geron Corporation declared that the Marketing Authorization Application concerning imetelstat-a novel experimental telomerase inhibitor-has been accepted and validated by the EMA.
Drug Insights
4 min read
Decoding ajmaline: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
11 October 2023
This article summarized the latest R&D progress of ajmaline, the Mechanism of Action for ajmaline, and the drug target R&D trends for ajmaline.
Bio Sequence
2 min read
Investigating Sequence Modifications: An Exploration with Patsnap Bio Sequence Database
11 October 2023
To undertake a detailed exploration of sequence modifications and comprehend the associated specific patent information, we propose utilizing the Patsnap Bio sequence database. Boasting an extensive archive of patent literature and affiliated sequence data, this bio-database forms an invaluable tool for a thorough investigation.
Drug Insights
5 min read
Deep Scientific Insights on acetylcholine chloride's R&D Progress, Mechanism of Action, and Drug Target
11 October 2023
This article summarized the latest R&D progress of acetylcholine chloride, the Mechanism of Action for acetylcholine chloride, and the drug target R&D trends for acetylcholine chloride.
Latest Hotspot
3 min read
FDA approves priority review of Odronextamab BLA for relapsed/refractory follicular and diffuse large B-cell lymphoma
11 October 2023
FDA accepts Priority Review of Odronextamab BLA for Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma.